Skip to content

Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology

Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03223168
Enrollment
10
Registered
2017-07-21
Start date
2017-07-19
Completion date
2018-07-19
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failing Fontan Physiology, Pediatric Congenital Heart Disease

Brief summary

The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators

Interventions

Participants will receive Noninvasive negative pressure from the Hayek RTX ventilator for 30 minutes during diagnostic catheterization procedure.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Patients with Fontan physiology with clinical evidence of Fontan failure as defined by those with one of the following in addition to Fontan circulation: New York Heart Association Class II, fluid retention, cyanosis, protein losing enteropathy, renal/hepatic dysfunction and/or subjectively qualify for hemodynamic assessment (by primary cardiologist).

Exclusion criteria

1. Patients which will likely require intubation for catheterization 2. Severely depressed systemic ventricular systolic function 3. Baseline airway obstruction 4. Plastic bronchitis 5. Significant OUTFLOW obstruction

Design outcomes

Primary

MeasureTime frameDescription
Hemodynamics as characterized by change in pulmonary artery pressureBaseline, 45 MinutesPulmonary artery wedge pressure will be measured in millimeters of mercury (mmHg) at baseline and completion of noninvasive negative pressure ventilation.
Hemodynamics as characterized by change in pulmonary blood flowBaseline, 45 MinutesChange in pulmonary blood flow will be measured at baseline and completion of noninvasive negative pressure ventilation.
Hemodynamics as characterized by change in systemic arterial saturationBaseline, 45 MinutesSystemic arterial saturation measures the amount of oxygen in the blood stream. Systemic arterial saturation will be registered at baseline and completion of noninvasive negative pressure ventilation.
Hemodynamics as characterized by change in cardiac outputBaseline, 45 MinutesCardiac output will be measured in liters per minute at baseline and completion of noninvasive negative pressure ventilation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026